BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: Correlation with biological and clinical features

被引:43
|
作者
Bojarska-Junak, Agnieszka [1 ]
Hus, Iwona [2 ]
Chocholska, Sywia [2 ]
Wasik-Szczepanek, Ewa [2 ]
Sieklucka, Malgorzata [1 ]
Dmoszynska, Anna [2 ]
Rolinski, Jacek [1 ]
机构
[1] Med Univ Lublin, Dept Clin Immunol, PL-20954 Lublin, Poland
[2] Med Univ Lublin, Dept Hematooncol & Bone Marrow Transplantat, PL-20954 Lublin, Poland
关键词
B-CLL; BAFF; APRIL; ZAP-70; CD38; ZAP-70; EXPRESSION; TACI; AUTOIMMUNITY; STIMULATOR; DIAGNOSIS; MECHANISM; MYELOMA;
D O I
10.1016/j.leukres.2009.03.030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B-cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL) are involved in normal B cell survival and differentiation. We analyzed BAFF and APRIL plasma levels in patients with B-cell chronic lymphocytic leukemia (B-CLL). We also tested intracellular BAFF and APRIL expression in B-CLL and evaluated their prognostic relevance. The percentage of leukemic B cells with intracellular APRIL or BAFF expression correlated significantly with adverse prognostic factors such as ZAP-70 and CD38. Moreover, we found a close relationship between LPL protein expression or LPL/ADAM29 MFI ratio and proportion of B-CLL cells with intracellular BAFF or APRIL expression. Furthermore, patients with a low percentage of leukemic cells with intracellular BAFF or APRIL expression had a significantly longer overall survival than those with a high proportion of APRIL or BAFF positive leukemic cells. (c) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1319 / 1327
页数:9
相关论文
共 50 条
  • [21] Correlation of clinical data with proteomics profiles in 24 patients with B-cell chronic lymphocytic leukemia
    Voss, T
    Ahorn, H
    Haberl, P
    Döhner, H
    Wilgenbus, E
    INTERNATIONAL JOURNAL OF CANCER, 2001, 91 (02) : 180 - 186
  • [22] Functionality of the BAFF/APRIL system in B-cell acute lymphoblastic leukemia
    Sevdali, E.
    Katsantoni, E.
    Smulski, C. R.
    Kolokotsa, E. N.
    Vassilopoulos, G.
    Germenis, A. E.
    Eibel, H.
    Speletas, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 79 - 79
  • [23] MOLECULAR AND CLINICAL FEATURES OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA WITH OR WITHOUT STEREOTYPED B-CELL RECEPTORS: AN ITALIAN MULTICENTRIC EXPERIENCE
    Bomben, R.
    Dal Bo, M.
    Capello, D.
    Forconi, F.
    Zucchetto, A.
    Maffei, R.
    Laurenti, L.
    Bertoni, F.
    Bulian, P.
    Rossi, D.
    Del Principe, M., I
    Ilariucci, F.
    Sozzi, E.
    Spina, V
    Zucca, E.
    Degan, M.
    Lauria, F.
    Del Poeta, G.
    Efremov, D. G.
    Marasca, R.
    Gaidano, G.
    Gattei, V
    HAEMATOLOGICA, 2008, 93 : S91 - S91
  • [24] SERUM LEVEL OF BFGF AND HIS CORRELATION WITH BIOLOGICAL PARAMETERS IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
    Wasik-Szczepanek, E.
    Bojarska-Junak, A.
    Dmoszynska, A.
    Koczkodaj, D.
    Jarosz, M.
    Wach, M.
    Rolinski, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 601 - 601
  • [25] CD79b expression in B-cell chronic lymphocytic leukemia
    D'Arena, G
    Cascavilla, N
    Musto, P
    Bisogno, RC
    Pistolese, G
    Carotenuto, M
    HAEMATOLOGICA, 2000, 85 (05) : 556 - 557
  • [26] Study of fibromodulin gene expression in B-cell chronic lymphocytic leukemia
    Hassan, Doha Abd El-Hamid
    Samy, Rania Mohamed
    Abd-Elrahim, Osama Taha
    Salib, Caroline Sabry
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2011, 23 (01) : 11 - 15
  • [27] Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia
    Del Principe, Maria Ilaria
    Del Poeta, Giovanni
    Buccisano, Francesco
    Maurillo, Luca
    Venditti, Adriano
    Zucchetto, Antonella
    Marini, Rita
    Niscola, Pasquale
    Consalvo, Maria Antonietta Irno
    Mazzone, Carla
    Ottaviani, Licia
    Panetta, Paola
    Bruno, Antonio
    Bomben, Riccardo
    Suppo, Giovanna
    Degan, Massimo
    Gattei, Valter
    de Fabritiis, Paolo
    Cantonetti, Maria
    Lo Coco, Francesco
    Del Principe, Domenico
    Amadori, Sergio
    BLOOD, 2006, 108 (03) : 853 - 861
  • [28] Alemtuzumab for B-cell chronic lymphocytic leukemia
    Robak, Tadeusz
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (07) : 1033 - 1051
  • [29] Rituximab in B-cell chronic lymphocytic leukemia
    Lin, TS
    Lucas, MS
    Byrd, JC
    SEMINARS IN ONCOLOGY, 2003, 30 (04) : 483 - 492
  • [30] Alemtuzumab in B-cell chronic lymphocytic leukemia
    Shapira, I
    Grossbard, ML
    CLINICAL LYMPHOMA, 2004, 4 (04): : 228 - 229